CymaBay Therapeutics Inc. Free Cash Flow 2013-2023 | CBAY
CymaBay Therapeutics Inc. free cash flow from 2013 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| CymaBay Therapeutics Inc. Annual Free Cash Flow |
| 2023 |
-72.98 |
| 2022 |
-84.23 |
| 2021 |
-69.52 |
| 2020 |
-44.75 |
| 2019 |
-98.23 |
| 2018 |
-55.47 |
| 2017 |
-19.66 |
| 2016 |
-23.40 |
| 2015 |
-23.32 |
| 2014 |
-21.22 |
| 2013 |
-7.80 |
| 2012 |
-11.29 |
| CymaBay Therapeutics Inc. Quarterly Free Cash Flow |
| 2023-12-31 |
-72.98 |
| 2023-09-30 |
-45.42 |
| 2023-06-30 |
-19.27 |
| 2023-03-31 |
6.24 |
| 2022-12-31 |
-84.23 |
| 2022-09-30 |
-65.46 |
| 2022-06-30 |
-47.93 |
| 2022-03-31 |
-25.36 |
| 2021-12-31 |
-69.52 |
| 2021-09-30 |
-55.28 |
| 2021-06-30 |
-39.86 |
| 2021-03-31 |
-20.66 |
| 2020-12-31 |
-44.75 |
| 2020-09-30 |
-29.93 |
| 2020-06-30 |
-22.46 |
| 2020-03-31 |
-14.71 |
| 2019-12-31 |
-98.23 |
| 2019-09-30 |
-70.06 |
| 2019-06-30 |
-46.92 |
| 2019-03-31 |
-22.57 |
| 2018-12-31 |
-55.47 |
| 2018-09-30 |
-35.40 |
| 2018-06-30 |
-19.31 |
| 2018-03-31 |
-6.49 |
| 2017-12-31 |
-19.66 |
| 2017-09-30 |
-13.56 |
| 2017-06-30 |
-8.09 |
| 2017-03-31 |
-2.20 |
| 2016-12-31 |
-23.40 |
| 2016-09-30 |
-17.99 |
| 2016-06-30 |
-12.25 |
| 2016-03-31 |
-6.14 |
| 2015-12-31 |
-23.32 |
| 2015-09-30 |
-18.13 |
| 2015-06-30 |
-11.47 |
| 2015-03-31 |
-6.16 |
| 2014-12-31 |
-21.22 |
| 2014-09-30 |
-13.75 |
| 2014-06-30 |
-9.84 |
| 2014-03-31 |
-5.04 |
| 2013-12-31 |
-7.80 |
| 2013-09-30 |
-4.47 |
| 2013-06-30 |
-4.17 |
| 2013-03-31 |
-2.16 |
| 2012-09-30 |
-10.91 |
